Karin E de Visser

22PUBLICATIONS
120CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Psychosocial aspects of childbirth and perinatal mental healthCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jan 22, 2025
Triple-negative breast cancer modifies the systemic immune landscape and alters neutrophil functionality.

Noor A M Bakker, Hannah Garner, Ewald van Dyk

|Sep 16, 2024
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial.

Iris Nederlof, Olga I Isaeva, Manon de Graaf

|Jul 14, 2023
Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features.

Hanne Lefrère, Kat Moore, Giuseppe Floris

|Apr 24, 2023
Neoadjuvant immune checkpoint blockade triggers persistent and systemic Treg activation which blunts therapeutic efficacy against metastatic spread of breast tumors.

Olga S Blomberg, Kevin Kos, Lorenzo Spagnuolo

|Apr 10, 2023
PD-L1 blockade in combination with carboplatin as immune induction in metastatic lobular breast cancer: the GELATO trial.

Leonie Voorwerk, Olga I Isaeva, Hugo M Horlings

|Jan 30, 2023
Mechanisms driving the immunoregulatory function of cancer cells.

Antoinette van Weverwijk, Karin E de Visser

Pageof 4

Frequent Collaborators

6 joint publications

Marleen Kok

6 joint publications

Lodewyk Wessels

5 joint publications

Hugo M Horlings

4 joint publications

Ton N Schumacher